The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
LDN Protects Bone Property Deterioration at Different Hierarchical Levels in T2DM Mice Bone
ACS Omega
10 Aug 2021
https://pubmed.ncbi.nlm.nih.gov/34395985/
Dr Jill Cottel, LDN Radio Show 30 Nov 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Welcome Jill! How does it feel to be our first guest on the new LDN Radio Show?
Dr Jill Cottel: Hello, Linda. It's very exciting.
Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs)
Int Immunopharmacol
December 2013
https://www.ncbi.nlm.nih.gov/pubmed/24455776
Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.